The Trump administration is delaying the release of TrumpRx, an online platform that lets people buy prescription drugs directly from pharmaceutical companies at a discount, according to Politico. While the reason for the delay is unclear, it comes as Democratic senators raise questions about how the platform will work—and whether it will be legal.
Sens. Dick Durbin (D-Ill.), Elizabeth Warren (D-Mass.), and Peter Welch (D-Vt.) sent a letter to the Office of Inspector General at the Department of Health and Human Services on Thursday seeking answers on how the OIG will oversee the direct-to-consumer (DTC) platform and, specifically, how it will apply the anti-kickback statute.
“Legitimate concerns about inappropriate prescribing, conflicts of interest, and inadequate care have been raised about the exact types of DTC platforms to which TrumpRx would route patients,” the senators write.
Read full article
Comments
